Gujarat provides over Rs 14 Cr in free treatment to 14,925 sickle cell patients in four years
Gandhinagar, Aug 7
The Gujarat government has provided more than Rs 14.57 crore in free medical assistance to over 14,925 patients suffering from sickle cell anaemia over the past four financial years, as it continues to expand efforts to improve early diagnosis, treatment and long-term care for the inherited blood disorder, particularly in tribal areas of the state.
According to the Tribal Development Department, financial assistance has been extended under the state's 'Free Medical Assistance Scheme' during the period from 2023-24 to 2026-27.
The support is intended to help patients access treatment while reducing the financial burden associated with managing the chronic condition.
Beyond financial assistance, the government said it has adopted a broader healthcare strategy aimed at controlling the disease and improving patient outcomes.
Large-scale screening campaigns are being conducted across tribal regions to facilitate early detection of sickle cell anaemia, while diagnosed patients are being provided with regular medication, continuous follow-up care and access to specialist medical guidance.
"Awareness campaigns are also being carried out in rural and remote areas through coordinated efforts involving ASHA workers, healthcare personnel and local administrative authorities. These campaigns are intended to improve public awareness of the disease and encourage timely diagnosis and treatment," official said.
For patients requiring advanced medical intervention, the government said referral mechanisms and higher-level treatment facilities have been strengthened to ensure timely access to quality healthcare.
It added that "its efforts are being undertaken in coordination with the Central government's national mission for the elimination of sickle cell anaemia".
"The state government remains fully committed to the overall health and welfare of the tribal community. Joint and coordinated efforts by the Health Department and the Tribal Development Department for the effective control and eradication of sickle cell anaemia will continue to be intensified and expanded in the coming years," the department said.
Sickle cell anaemia disproportionately affects tribal populations in Gujarat, where screening, early diagnosis and continuous treatment have been key components of the state's public health strategy to reduce complications associated with the disease.
— IANS
Reader Comments
Good to see the focus on early screening in remote areas. The involvement of ASHA workers is key—they are the backbone of rural healthcare. But I hope the government also ensures that the referral facilities are actually accessible to those in far-flung villages. Awareness is good, but follow-through matters.
Impressive numbers—nearly 15,000 patients treated in four years. It's heartening to see state governments in India prioritising rare genetic disorders from a public health perspective. The central-state coordination on the sickle cell mission is a good template for other health programmes.
My cousin from a tribal area in Gujarat benefits from this scheme, and it's made a huge difference for our family. The medicines are expensive, so this support is a lifeline. But the awareness campaigns need to be more frequent—many people still don't know about the free treatment option. 😊
As someone who's followed India's public health initiatives, this is a solid move. Sickle cell disease is often overlooked, especially in tribal communities. The emphasis on early diagnosis and continuous care is exactly what's needed. I just hope the funding keeps pace with the rising number of screenings.
Good initiative, but let's also talk about the need for genetic counselling and preventive measures. Treating existing patients is important, but we must also work on reducing the number of new cases through awareness about genetic transmission. The government should add that to the strategy.
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.